The researchers wanted to determine the value of LDL-C as a risk biomarker for coronary heart disease, atherosclerotic cardiovascular disease, and stroke events and deaths for people stratified by age.
The researchers believe the results of this study highlight the need for an effective screening tool for thyroid cysts among the general population.
The expanded approval was based on data from a phase 3 study that evaluated exenatide extended-release in 82 patients aged 10 to 17 years with type 2 diabetes.
Researchers sought to delineate the role of cystic fibrosis transmembrane conductance regulator (CFTR) in pulmonary arterial hypertension pathogenesis through observational and interventional experiments in human tissues and animal models.
The researchers’ goal was to determine the dominant predictors for dilations at the ascending, arch, descending, and abdominal part of the aorta, and to establish comprehensive risk factor profiles for each aortic segment.
Each additional cup of habitual coffee consumed reduced the risk of incident arrhythmia by 3%.
Researchers evaluated the role of ventricular-arterial coupling from 3D echocardiography in predicting clinical outcomes in patients with systemic sclerosis.
This review explores the cardiovascular consequences of opioids and the contributions of off-target electrophysiologic properties to mortality, and provides practical safety recommendations.
This review examines the current guidance and issues related to lipid optimization of patients with peripheral arterial disease (PAD).
Dapagliflozin’s benefits among patients with stage 4 CKD were consistent with those observed in the larger DAPA-CKD cohort with stage 2-3 CKD.